US Stocks
/
BiomX Inc. Share Price

BiomX Inc. Share Price

AMEX: PHGE | Micro Cap
$0.17
+$0.01 (7.43%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

BiomX Inc. Stock Performance

Open
$0.16
Prev. Close
$0.16
Circuit Range
N/A
Day Range
$0.16 - $0.17
Year Range
$0.16 - $8.49
Volume
4,246
Average Traded
$0.17

BiomX Inc. Share Price Today

As of 10 August 2026, BiomX Inc.'s share price is $0.17. The stock opened at $0.16, compared to its previous close of $0.16. During today's trading session, BiomX Inc.'s share price traded between $0.16 and $0.17, with an average price of $0.17. Over the past 52 weeks, the stock has recorded a high of $8.49 and a low of $0.16. In terms of performance, BiomX Inc.'s share price has declined by 96.04% over the last six months and is down 68.51% on a year-on-year basis.

BiomX Inc. Share Price Chart

$0.16$0.17
L
Show Current Price
H

BiomX Inc. Stock Fundamentals & Key Indicators

Market Cap
$275808.36
PE Ratio (TTM)
0.01
Dividend Yield
N/A
EPS (TTM)
$22.19
Revenue (TTM)
N/A
Return On Equity (TTM)
2780.26%
Profit Margin
N/A
Debt to Equity
-4.90
Quarterly Earnings Growth YoY
-195.06%

BiomX Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$17.33M$4.47M$9.64M-$7.66M-$6.04M-$9.17M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A125.80%115.66%-179.43%21.18%-51.83%

BiomX Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
RevenueN/AN/AN/AN/A
Net Profit-$28.32M-$26.17M-$17.73M-$36.20M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A7.59%32.26%-104.20%

About BiomX Inc.

BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. It also developing BX004, a phage therapy for cystic fibrosis and non-cystic fibrosis bronchiectasis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. The company was founded in 2015 and is headquartered in Ness Ziona, Israel.

BiomX Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.18
$0.17
-8.65%
Jul 2026
$0.32
$0.18
-45.27%
Jun 2026
$1.14
$0.34
-73.39%
May 2026
$0.79
$1.27
+51.73%
Apr 2026
$3.70
$0.84
-78.43%
Mar 2026
$4.23
$3.88
-9.03%
Feb 2026
$5.86
$4.26
-26.72%
Jan 2026
$2.00
$5.82
+188.12%
Dec 2025
$4.25
$2.02
-53.88%
Nov 2025
$0.47
$4.38
+765.61%
Oct 2025
$0.53
$0.51
-1.56%
Sep 2025
$0.55
$0.51
-4.28%

PHGE Share Price FAQs

What is BiomX Inc. share price today?

chevron-up
BiomX Inc. share price today is $0.17 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of BiomX Inc. stock?

chevron-up
The 52 week high of BiomX Inc. stock is $8.49, while the 52 week low is $0.16 as of 8 Aug '26.

What is PHGE's market capitalisation today?

chevron-up
PHGE market capitalisation is $275808.36 as of August 10, 2026, at 5:38 am IST.

What is PHGE's net income for the last quarter?

chevron-up
PHGE's net income for the last quarter is -0.01B USD.

What is the 5 year returns of PHGE?

chevron-up
The 5 year returns of PHGE is -99.57% as on 8 Aug '26.

What is the high & low stock price of PHGE today?

chevron-up
PHGE stock price hit a high of $0.17 and low of $0.16 as of 8 Aug '26.

Can I buy PHGE shares in India?

chevron-up
Yes. You can buy PHGE in India by opening an international trading account.